Thus, ASAH1 inhibitors are gaining interest in cancer therapy and were found to trigger apoptosis in cancer cells; in this regard, ASAH1 inhibitors were shown to be effective in killing glioblastoma cancer stem cells as well as head and neck cancer cells (HNC) [57, 58]. Here, ASAH1 is linked to cancer.